ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,510, issued on May 20, was assigned to National University Corporation Tottori University (Tottori, Japan) and KanonCure Inc. (Yonago, Japan).

"Inhibitory effect of low molecular weight compound on cancer and fibrosis" was invented by Goshi Shiota (Yonago, Japan), Noriko Itaba (Yonago, Japan), Keita Kanki (Yonago, Japan), Kenzo Seto (Yonago, Japan), Hiroki Shimizu (Yonago, Japan), Yohei Kouno (Yonago, Japan), Shinya Kunita (Yonago, Japan), Zyunya Adumi (Yonago, Japan), Tomohiko Sakabe (Yonago, Japan), Kenichiro Abe (Yonago, Japan), Minoru Morimoto (Tottori, Japan) and Hiroyuki Oka (Tottori, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A nove...